Decision to Grant Patent for Cymerus MSC Technology in Japan
Filed with ASX · · 1 page · English
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Cynata & Regience Extend Entitlement Period
- Compelling Results from Pre-Clinical Stem Cell Study in GvHD
- Cynata Announces Landmark Licensing Deal
- Cynata Enters Agreement for Strategic Alliance in Japan
- Cynata Receives $930k R&D Tax Incentive Refund
Later from Cynata Therapeutics
- CYP Manufactures CT Product-Files Further Patent Application
- Cynata Enters Agreement with apceth GmbH & Co KG
- Cynata Prepares for Phase 1 Clinical Trial
- Cynata Receives Investment Offer from Regience
- Cynata Files Application to Commence Phase 1 Clinical Trial
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics